Kyle Horvath

Kyle Horvath is an experienced professional in the field of molecular biology and next-generation sequencing, currently serving as Manager and formerly Senior Scientist at Guardant Health, where contributions led to the successful approval of Guardant360 CDx as a companion diagnostic for Rybrevant. Prior experience includes serving as the technical lead for assay development at ResearchDx, where roles evolved from Research Scientist I through Senior Scientist, focusing on molecular biology and NGS technologies. Academic credentials include a Ph.D. in Biology from Johns Hopkins University and a Bachelor's Degree in Biochemistry and Molecular Biology from UC Irvine, complemented by research experience in proteomics and chromatin dynamics.